* Alimera Sciences Inc ALIM.OQ ALIM.O is expected to show a
fall in quarterly revenue when it reports results on October
28.
* The Alpharetta, Georgia-based company is expected to report a
0.8% decrease in revenue to $12.37 million from $12.47 million a
year ago, according to the mean estimate from 3 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Alimera Sciences Inc is
for a loss of 52 cents per share. For the same quarter last
year, the company reported a loss of 12 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Alimera
Sciences Inc is $14.5, about 69.7% above its last closing
price of $4.40.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Jun. 30 2021 1.05 1.06 0.72 Missed -32.1
Mar. 31 2021 -0.52 -0.54 -0.63 Missed -16.7
Dec. 31 2020 -0.04 -0.04 -0.18 Missed -315.4
Sep. 30 2020 -0.44 -0.44 -0.12 Beat 72.9
Jun. -1.09 -1.61 -0.51 Beat 68.4
30 2020
Mar. 31 2020 -0.44 -0.43 -0.24 Beat 44.5
Dec. 31 2019 -0.35 -0.45 0.08 Beat 117.7
Sep. 30 2019 -0.57 -0.60 -0.60 Met 0
This summary was machine generated October 27 at 07:39 GMT. All
figures in US dollars unless otherwise stated